Engineered extracellular vesicles as brain therapeutics.

Area of Science:

• Neuroscience
• Biotechnology
• Nanomedicine

Background:

• Extracellular vesicles (EVs) act as crucial intercellular communication mediators in the brain and between the brain and periphery.
• EVs play significant roles in both normal physiological functions and disease processes.
• Their potential to traverse the blood-brain barrier (BBB) positions them as promising nanocarriers for brain disease therapeutics.

Purpose of the Study:

• To review the therapeutic applications of native and bioengineered EVs for various brain diseases.
• To examine the interaction of EVs with the BBB.
• To discuss challenges and opportunities for the clinical translation of EV-based brain therapeutics.

Main Methods:

• Literature review of studies on native and engineered EVs for brain pathologies.
• Analysis of data regarding EV interaction with the BBB.
• Discussion of clinical translation challenges and prospects.

Main Results:

• EVs can be engineered to enhance their biological activity, stability, and targeting capabilities.
• Native and engineered EVs have demonstrated therapeutic potential for diverse brain pathologies.
• Current limitations include modest brain accumulation and restricted local therapeutic effects.

Conclusions:

• EVs hold significant therapeutic potential for brain diseases due to their inherent properties and engineerability.
• Overcoming challenges related to EV brain accumulation and targeting is key for clinical success.
• Further research into EV-BBB interactions and clinical translation is warranted.